Kazuko Matsuda

Kazuko Matsuda

DirectoratMedicinova· In proxies 2022–2025

Pay in FY2023+14% from the year before · Medicinova stock -26.8% the same year

Kazuko Matsuda was paid $1.0M in FY2023 (Dec), up 14%. Medicinova stock fell 26.8% that year.

Pay$100 in the stock at the end of FY21 → $56
Pay is from the Summary Compensation Table of each Medicinova proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MedicinovaPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role -47%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?